BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4535200)

  • 1. [Mucocutaneous lesions produced by Leishmania Braziliensis].
    Lasala Carreras A
    Acta Odontol Venez; 1974 Apr; 12(1):3-21. PubMed ID: 4535200
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological, clinical and biological features of mucocutaneous leishmaniasis in Bolivia after a 221 patient sample].
    Dimier-David L; David C; Muñoz M; Vargas F; Bustillos R; Valda L; Dedet JP
    Bull Soc Pathol Exot; 1993; 86(2):106-11. PubMed ID: 8353467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of amphotericin B in mucocutaneous leishmaniasis.
    Crofts MA
    J Trop Med Hyg; 1976 May; 79(5):111-3. PubMed ID: 933229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective liquid medium for primary isolation of South American Leishmanias.
    Palomino JC; Guerra H; Lumbreras H
    Tropenmed Parasitol; 1983 Dec; 34(4):229-32. PubMed ID: 6665867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [American leishmaniasis of the skin and mucous membranes and its treatment with amphotericin B (author's transl)].
    Mayer PJ
    MMW Munch Med Wochenschr; 1974 Sep; 116(36):1539-46. PubMed ID: 4215958
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity.
    Saravia NG; Holguín AF; McMahon-Pratt D; D'Alessandro A
    Am J Trop Med Hyg; 1985 Jul; 34(4):714-20. PubMed ID: 4025684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmaniasis of the tongue in a renal transplant recipient.
    Alrajhi AA; Saleem M; Ibrahim EA; Gramiccia M
    Clin Infect Dis; 1998 Nov; 27(5):1332-3. PubMed ID: 9827301
    [No Abstract]   [Full Text] [Related]  

  • 10. [South american mucocutaneous Leishmaniasis in the region of the Rio Pachitea (author's transl)].
    Heimgartner E; Heimgartner V
    Dermatologica; 1974; 149(4):248-52. PubMed ID: 4376499
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro culture as a practical tool for the diagnosis and primary isolation of Leishmania braziliensis braziliensis. 2. Studies in patients in endemic areas].
    Cuba Cuba CA; Netto EM; Costa JL; Barreto AC; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):317-24. PubMed ID: 3589393
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Treatment of Saudi Arabian cutaneous leishmaniasis.
    Morsy TA; Shoura MI
    J Trop Med Hyg; 1974 Mar; 77(3):68. PubMed ID: 4830286
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal leishmaniasis . Current scenario and prospects for treatment.
    Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
    Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological features of cutaneous leishmaniasis americana in an endemic region of the state of Bahia, Brazil. I. Human leishmaniasis].
    Barretto AC; Cuba CA; Marsden PD; Vexanat JA; De Belder M
    Bol Oficina Sanit Panam; 1981 May; 90(5):415-24. PubMed ID: 6456727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Amphotericin B in the treatment of the otorhinolaryngological forms of paracoccidioidomycosis and leishmaniasis resistent to sulfas and antimonial agents].
    Albernaz PL; Lanzellotti WP; Ganança MM
    Hospital (Rio J); 1968 Sep; 74(3):913-20. PubMed ID: 5310129
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent.
    Aguayo-Carreras P; Cuenca-Barrales C; Perez-López I; Ruiz-Villaverde R; Tercedor-Sanchez J
    Int J Dermatol; 2019 Jul; 58(7):e137-e138. PubMed ID: 30883705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amphotericin B in the treatment of otorhinolaryngologic forms of paracoccidioidosis and leishmaniasis resistant to sulf as the antimonials].
    Albernaz PL; Lanzellotti WP; Ganança MM
    Hospital (Rio J); 1968 Sep; 74(3):913-20. PubMed ID: 5303774
    [No Abstract]   [Full Text] [Related]  

  • 18. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
    Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD
    J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [South American leishmaniasis in medical practice. Therapeutic problems].
    Heimgartner E; Krebs A
    Schweiz Rundsch Med Prax; 1985 Jul; 74(29):779-83. PubMed ID: 3898301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protozoan infections of the skin].
    Müller E; Sturm G
    Hautarzt; 1974 Jun; 25(6):293-7. PubMed ID: 4546650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.